7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment

A conversation with Sebastien Groyer, Entrepreneur and Venture Capitalist

  
0:00
-1:39:17

In 16 years of supporting life science companies in raising capital and structuring deals with the pharma industry, I never felt that venture capital exists in abundance on the European market.

It always seemed that the market is very VC-friendly on the European stage - plenty of teams and technology meet with a scarcity of available funds.

This was the reason to start the LSG2G Lunch MeetUps in June 2017. I remember our first meetup with 15 Life Science Enthusiasts like Pharma Business Developer, Life Science Investors, Life Science Entrepreneurs, and Service Partners. We discussed the state of Investments in Biotech in Europe.

As the first meetup was well received, the LSG2G Partners organized one every three months, an investment conference, and during the pandemic, created a podcast.

Availability of Venture Capital in Europe

According to Dealroom.co 2017, the transaction volume in life science companies in 2017 was about 3,7 billion euros.

In 2020 investments increased to 6 billion Euros, which was already achieved by July this year. It looks promising to see investments double since we started the LSG2G initiative in the last four years.

Sebastien Groyer - 20 Years Experience in Life Science Venture Investments

So far, to the analytics of Venture Investments in Biotech in Europe. Numbers are fine but leave a few important questions open.

  • Who are the people behind those numbers?

  • What stories did they write in their career?

  • What lessons did they learn in the world of VC Investments?

Business is always done between people, and sharing stories helps to understand how an industry works and how deep tech can be transformed into products that help the patients.

I am delighted to welcome to this episode Sebastien Groyer who brings 20 years of profound investment expertise to the conversation table. In this episode, he will share

7 Tales from 20 Years of Deep Tech Life Science Investments

and also will tell why he turned into a serial entrepreneur in 2021.

Video to this Episode:

Youtube


Timestamps:

00:00 Introduction

02:35 How do VCs view planning in companies?

05:59 How to Approach Investors when Plans Change

11:00 What are Target Companies of VCs?

15:15 Are VCs Going for First Movers or Rather Established Markets?

19:30 How Detailed Should  Business Plans be when Pitching to VCs?

23:50 Storytelling – From Rough to Detail

27:15 The Reality of VC Life

34:40 How Often Can You Follow Up with VCs before Ending Up on a Blacklist

38:54 What is the Right Time to Approach VCs?

40:40 How do VCs view companies in Fundraising Mode?

46:10 The Fundraising Process in a Company

48:15 Is the Fundraisngprocess Transactional, or do Relationships matter?

51:00 Fundraising – Similarities and Differences between the US and the European Approach

56:50 Entrepreneurship and Investors – Lifestyle or a Job?

01:00:00 The Role of Money in Different Societies

01:04:00 Why Do VCs Search for Exits?

01:11:00 Valuation Expectations of VCs

01:14:00 It is all about growth

01:19:00 When Does it Make Sense to Reach out to VCs?

01:23:00 Differences in the Value of Information in the B2B and B2C world

01:27:00 The Pros and Cons of being an Investor or Entrepreneur

01:30:00 Spirituality, Investment, and Entrepreneurship

01:34:30 What is the most important thing to consider when reaching out to VCs?


Join Our Conversations:

I am delighted to announce that the LSG2G Partner, Diagnostics Expert, and Business Angel Albert Missbichler invites us to a Get2gether in his wine cellar in the Vineyards of Vienna.

  • When? October 10, 2021 - 3:30 PM

  • Where? Stammersdorfer Kellergasse 106, 1210 Vienna - Austria

  • Price? EUR 28,- for buffet and welcome drink (payment at the event)

  • Music? Jazz, Viennese Chants, and Opera

Due to the current corona measures, the event is limited to 50 guests, and the latest corona rules apply. Please make sure that you are either vaccinated or have a negative PCR test result to participate in this event.

First, come - first serve principle.

It would be great to welcome you in person - Albert Missbichler and Christian Soschner will be there.

Interested?

Register today with a brief eMail to

Mail To


Community Partner:

These companies make the community, this newsletter, and the LSG2G Podcast possible, so go check them out and thank them for their support!

Partner Links


You are receiving the LSG2G-Letter because you either signed up or attended one of the events organized by LSG2G. Feel free to unsubscribe if you aren’t finding this valuable.

Nothing in this email is intended to serve as financial advice. Do your own research.